Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair
Oncotarget
.
2023 Jul 20:14:722.
doi: 10.18632/oncotarget.28479.
Authors
Jianli Zhou
1
,
Drew Sturtevant
1
,
Cassie Love
2
,
Aditya Kulkarni
1
,
Neha Biyani
1
,
Umesh Kathad
1
,
Elizabeth Thacker
3
,
Sandeep Dave
2
,
Kishor Bhatia
1
Affiliations
1
Lantern Pharma Inc., Plano, TX 75024, USA.
2
Department of Medicine, Duke University, Durham, NC 27708, USA.
3
Data Driven Bioscience, Durham, NC 27707, USA.
PMID:
37477520
PMCID:
PMC10360926
DOI:
10.18632/oncotarget.28479
No abstract available
Publication types
Published Erratum